McCowan Colin, Neville Ron G, Hoskins Gaylor
Mackenzie Building, University of Dundee, Tayside Centre for General Practice, Kirsty Semple Way, Dundee, DD2 4BF, UK.
Prim Care Respir J. 2005 Apr;14(2):106-11. doi: 10.1016/j.pcrj.2004.10.008.
To investigate whether a patient review service changes the management of asthma in accordance with BTS/SIGN Guidelines.
An observational study of routine review consultations for patients with asthma registered at 862 practices throughout the United Kingdom. Practices recorded reviews on a computer template and returned the information to an academic unit for analysis.
41,493 patients had data returned with 14,790 (36%) patients reporting symptoms at rest or on a daily basis and 15,840 (38%) patients over-using their short-acting beta2-agonist. 4,556 (74%) of patients with symptoms who had a subsequent consultation reported a reduction in their symptoms, whilst 3,932 (63%) reported a reduction in short-acting beta2-agonist use. Night-time, daytime, and activity symptom scores, and short-acting beta2-agonist use, were significantly reduced for patients reviewed more than once.
There are a large proportion of patients suffering symptoms at rest or on a daily basis. There was a significant reduction in symptom levels and use of reliever medication for patients who were reviewed. A review service implementing the BTS/SIGN guidelines for asthma management would seem to improve patient outcomes.
调查患者评估服务是否会根据英国胸科学会/苏格兰校际指南网络（BTS/SIGN）指南改变哮喘的管理方式。
对英国862家医疗机构登记的哮喘患者的常规评估咨询进行观察性研究。医疗机构在计算机模板上记录评估情况，并将信息返回给一个学术单位进行分析。
41493名患者的数据被返回，其中14790名（36%）患者报告有静息或日常症状，15840名（38%）患者过度使用短效β2激动剂。在有症状且随后进行了咨询的患者中，4556名（74%）报告症状减轻，而3932名（63%）报告短效β2激动剂使用减少。接受多次评估的患者的夜间、白天和活动时的症状评分以及短效β2激动剂的使用均显著降低。
有很大比例的患者有静息或日常症状。接受评估的患者的症状水平和缓解药物的使用显著降低。实施BTS/SIGN哮喘管理指南的评估服务似乎会改善患者的治疗效果。
